InfuCare Rx, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

InfuCare Rx, Inc. - overview

Established

2014

Location

Fairfield, NJ, US

Primary Industry

Healthcare

About

Based in New Jersey, US, and founded in 2014, InfuCare Rx, Inc. operates as a healthcare software company that provides a therapy management platform. The company was founded by its CEO Deven Patel. In November 2025, Guggenheim Investments, along with the company's management, acquired InfuCare Rx, Inc.


from One Equity Partners, as part of recapitalization. InfuCare operates an online platform called InfuCare Rx Health that delivers infusion treatment and clinical therapy management services such as digital prescriptions, secure real-time medical data, and telemedicine for patients with severe or chronic diseases and infections, including anti-infective and immunoglobulin therapy, chronic inflammation, parenteral nutrition, and specialty injectables.


Current Investors

One Equity Partners

Primary Industry

Healthcare

Sub Industries

Hospitals, Home Healthcare, Nursing Homes & Assisted Living, Clinics/Outpatient Services, Healthcare IT, Medical Software

Website

www.infucarerx.com

Verticals

Cloud Computing, HealthTech, Mobile Apps

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

InfuCare Rx, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary BuyoutCompletedInfuCare Rx, Inc.-
GrowthCompletedInfuCare Rx, Inc.-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.